Songping Huang

Songping Huang is a Professor at Kent State University, affiliated with the College of Arts and Sciences and the Department of Chemistry and Biochemistry. His research focuses on three interconnected areas: developing novel antimicrobial agents to combat antibiotic resistance, exploring ferroptosis mechanisms for cancer chemotherapy, and designing nanoparticle-based contrast agents for medical imaging. His work integrates medicinal chemistry, materials science, and biomedical engineering to address critical challenges in healthcare.

Research spans rational drug design of small molecules targeting unique bacterial pathways (e.g., NDH-2 inhibitors), iron-based metallodrugs exploiting cancer cell vulnerabilities through ferroptosis, and Prussian blue nanoparticles for gastrointestinal MRI diagnostics. Huang's team collaborates extensively with clinical researchers to translate findings into therapeutic applications.

Recent publications demonstrate a strong focus on nanomedicine and metal-based therapeutics. Article analyses reveal predominant themes in antimicrobial nanomaterials (45% of recent works), cancer treatment innovations (30%), and advanced imaging technologies (25%), with increasing emphasis on overcoming multidrug resistance through novel mechanisms.

Laboratory: Leads the Huang Research Group at the Advanced Materials and Liquid Crystal Institute, focusing on interdisciplinary approaches to biomedical challenges.